Mobile Menu - OpenMobile Menu - Closed

Congressman Krishnamoorthi Applauds Passage Of Resolution He Cosponsored Urging The Biden Administration Support India’s COVID-19 Response And Protect the U.S.

June 30, 2021
Press Release
Krishnamoorthi Has Also Introduced The NOVID Act To Dramatically Expand And Accelerate US Global Vaccine Aid

WASHINGTON –Congressman Raja Krishnamoorthi applauded yesterday’s passage of H.Res.402, which he cosponsored, a House resolution recognizing the devastating impact of COVID-19 in India and expressing the sense of the House of Representatives that, given India’s COVID-19 crisis, the United States needs to send critical medical supplies to India. As a cosponsor of the resolution and member of the India Caucus, Congressman Krishnamoorthi supports U.S. efforts to mitigate the COVID-19 pandemic on a global scale, especially in countries most impacted, such as India.

In order to further the efforts of this resolution, Congressman Krishnamoorthi has also introduced the bicameral Nullifying Opportunities for Variants to Infect and Decimate (NOVID) Act to expand the U.S. global vaccination efforts. The NOVID Act will scale up manufacturing capacity to produce 8 billion vaccine doses, immunize 60% of the populations in the 92 COVAX countries including India, and establish a global disease surveillance network to protect against future pandemics.

“This vote shows that support for global vaccination, and for India, is an overwhelmingly bipartisan sentiment in the United States House of Representatives. I’m pleased that my colleagues and I were able to pass H.Res.402 to express our nations’ need to support countries like India, which have been significantly impacted by devasting COVID-19 case rates,” Congressman Krishnamoorthi said. “That is why I’ve also introduced my NOVID Act to expand the role of the United States in ensuring that vaccinations make it into people’s arms across the globe. This will end the pandemic faster and protect the tremendous progress that the United States has made by limiting the change of a dangerous COVID-19 mutation developing overseas. This is a global pandemic that requires a global response."